Published Paper Details:

Asthma is a chronic inflammatory airway disease affecting millions worldwide and is associated with significant morbidity and reduced quality of life. Single Maintenance and Reliever Therapy (SMART) has improved asthma management; however, treatment success depends largely on patient knowledge, adherence, and self-management practices. Objective: To evaluate the impact of patient counselling on knowledge, attitude, practice (KAP), medication adherence, and quality of life among asthma patients receiving SMART therapy. Methods: A prospective observational study was conducted among 20 asthma patients receiving SMART therapy in a tertiary care hospital. Baseline and follow-up assessments of KAP, medication adherence, and quality of life were performed before and after counselling. Data were analyzed using the Wilcoxon Signed-Rank Test, with p < 0.05 considered statistically significant. Results: Significant improvements were observed following counselling. Mean knowledge scores increased from 60% to 88% (p=0.001), attitude scores from 66% to 82% (p=0.004), practice scores from 52% to 78% (p=0.001), and medication adherence scores from 54% to 79% (p=0.001). Quality-of-life scores improved significantly from 48% to82% (p=0.014). Conclusion: Patient counselling significantly improved KAP, medication adherence, and quality of life among asthma patients receiving SMART therapy, highlighting the important role of pharmacists in asthma management.